(Q36185805)

12 August 2017

Developing a 'traffic light' test with potential for rational early diagnosis of liver fibrosis and cirrhosis in the community (English)

1 reference

12 August 2017

0 references

Nick Sheron

1

1 reference

12 August 2017

Mike Moore

2

1 reference

12 August 2017

Stacey Ansett

3

1 reference

12 August 2017

Camille Parsons

4

1 reference

12 August 2017

Adrian Bateman

5

1 reference

12 August 2017

language of work or name

1 reference

1 September 2012

1 reference

British Journal of General Practice

12 August 2017

1 reference

12 August 2017

62

1 reference

12 August 2017

602

1 reference

12 August 2017

e616-24

1 reference

Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426600

Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426600

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426600

Trends in European liver death rates: implications for alcohol policy.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426600

Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426600

Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426600

Non-invasive diagnostic tests for non-alcoholic fatty liver disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426600

Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426600

Spectrum bias--why clinicians need to be cautious when applying diagnostic test studies

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426600

Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: a meta-analysis with individual data

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426600

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426600

Are the opportunities to prevent alcohol related liver deaths in the UK in primary or secondary care? A retrospective clinical review and prospective interview study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426600

Trends in mortality after hospital admission for liver cirrhosis in an English population from 1968 to 1999.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426600

The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426600

Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426600

Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426600

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426600

A Meta-analysis of Transient Elastography for the Detection of Hepatic Fibrosis

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22947582

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3399/BJGP12X654588

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22947582

1 reference